The spread of false information and conspiracy theories accelerated during the peak of the COVID-19 pandemic. Inadvertently inaccurate, and some deliberately misleading, ideas were widely shared on social… read more.
The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic… read more.
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly… read more.
Gilead Sciences, Inc. announced that the FDA approved a supplemental new drug application (sNDA) for the use of Veklury (remdesivir) with no dose adjustments to treat COVID-19 in… read more.
The number of girls diagnosed with precocious puberty increased during the COVID-19 pandemic due to potential risk factors such as increased screen time and less physical activity, according to… read more.
Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for… read more.
During the pandemic, contact tracing apps kept Americans informed of potential exposure risk with the goal of reducing infections. But did apps like this help reduce the spread… read more.
A small, randomised trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy (HBOT) promotes restoration of the heart’s ability to contract properly. The research was… read more.
Vaccines against COVID-19, administered in the EU in the autumn of 2023, will be updated to target XBB forms of the SARS-CoV-2 virus. These strains are a subgroup… read more.
Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on… read more.
Researchers interviewed primary care clinicians to identify trends, facilitators and barriers in implementing and using telemedicine technologies in response to the COVID-19 pandemic. They interviewed 25 leaders from… read more.
Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
